ArticleOncotarget2017

CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.

Jian Ming Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.